Profound Medical Corp (PROF) is a Healthcare · Medical Devices company listed on NASDAQ. Price $5.86 (-0.51%), Market cap $0.25B, 52-week low–high $3.87 ~ $8.65.
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseased tissue. The company's lead product TULSA-PRO system combines magnetic resonance imaging (MRI), robotically driven transurethral sweeping action/thermal ultrasound and closed-loop temperature feedback control to ablate whole gland or physician defined region of malignant or benign prostate tissue. It also provides Sonalleve, which combines real-time MRI and thermometry for the treatment of uterine fibroids, adenomyotic tissue, palliative pain treatment of bone metastases, osteoid osteoma, and
Financial statements, price targets, institutional (13F) holdings and related news for Profound Medical Corp are updated in real time on BlackAll Trade.
Profound Medical Corp trades at $5.86 (-0.51%). Real-time quotes and charts are available on BlackAll Trade.
Profound Medical Corp has a market cap of about $0.25B.
Profound Medical Corp. operates as a commercial-stage medical device company that develops and markets AI-powered, MRI-guided, incision-free therapeutic systems for the image guided ablation of diseas